Federal Register / Vol. 75, No. 98 / Friday, May 21, 2010 / Notices 28623 

public about that topic. FDA uses the 

feedback provided by the public to 

update this resource. 

Phase II is the subject of this 

document and is described in more 

detail in section II of this document. 

Phase III of the Transparency 

Initiative will address ways FDA can 

become more transparent to regulated 

industry, to foster a more efficient and 

cost-effective regulatory process. The 

Task Force solicited comments from the 

public on this topic in March 2010 (75 

FR 11893, March 12, 2010) and draft 

proposals from this phase are expected 

in the summer of 2010. 

II. Phase II: Public Disclosure 

The second phase of the Transparency 

Initiative relates to FDA’s policies on 

disclosure of information to the public 

about FDA activities. FDA is releasing a 

report that contains 21 draft proposals 

that we are issuing for public comment. 

The draft proposals, along with 

background material, can be found on 

the FDA Web site at www.fda.gov/ 

transparency. FDA is accepting 

comments from the public on the draft 

proposals on the FDA Web site as well 

as through the docket (see section III of 

this notice). 

The Task Force solicited comments 

from the public about information FDA 

should provide to the public about what 

FDA is doing, the bases for the agency’s 

decisions, and the processes used to 

make agency decisions. The Task Force 

reviewed and considered all the 

comments received from a range of 

stakeholders. The Task Force also 

identified on its own initiative ways to 

improve transparency that are reflected 

in the report. 

In the report, the Task Force makes 

available for public comment 21 draft 

proposals for changes in policy related 

to the disclosure of information FDA 

has in its possession, while supporting 

the redaction of trade secrets and 

individually identifiable patient 

information from all documents 

proposed for disclosure. Other topics on 

which FDA plans to make changes or on 

which the Task Force is not proposing 

policy changes at this time are 

discussed in the ‘‘Other Areas of Public 

Comment’’ section of the report. 

After considering public comment on 

the draft proposals, the Task Force will 

recommend specific proposals to the 

Commissioner for consideration, and 

then FDA will announce which of the 

proposals it will implement, and the 

projected timeframe for implementation. 

Some of the draft proposals may require 

extensive resources to implement, and 

some may require changes to regulations 

or legislation. Therefore, in addition to 

input on the content of the proposals 

and whether the Task Force has struck 

the right balance with respect to the 

draft proposals, FDA is seeking input on 

how the agency should prioritize the 

proposals, if it decided to implement 

them. The Task Force will consider 

feasibility and priority, considering 

other agency priorities that require 

resources, when developing its specific 

recommendations for the Commissioner. 

III. Request for Comments 

FDA is interested in receiving 

comments from the public about the 

content of the draft proposals as well as 

on which draft proposals should be 

given priority. Interested persons may 

submit to the Division of Dockets 

Management (see ADDRESSES) either 

electronic or written comments 

regarding this document. It is only 

necessary to send one set of comments. 

It is no longer necessary to send two 

copies of mailed comments. Identify the 

draft proposal which your comment 

addresses by the number assigned to 

that proposal. Identify comments with 

the docket number found in brackets in 

the heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Comments can also be submitted on 

each draft proposal via the FDA Web 

site, www.fda.gov/transparency. 

Dated: May 17, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–12314 Filed 5–19–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

(CSAP) National Advisory Council will 

meet on June 9, 2010 from 1 p.m. to 4 

p.m. via teleconference. 

The meeting will include discussion 

and evaluation of grant applications 

reviewed by Initial Review Groups. 

Therefore, the meeting will be closed to 

the public as determined by the 

Administrator, SAMHSA, in accordance 

with Title 5 U.S.C. 552b(c)(6) and 5 

U.S.C. App. 2, Section 10(d). 

Substantive program information, a 

summary of the meeting, and a roster of 

Committee members may be obtained 

either by accessing the SAMHSA 

Committee’s Web site at https:// 

www.samhsa.gov/council/csap/ 

csapnac.aspx as soon as possible after 

the meeting, or by contacting CSAP 

National Advisory Council’s Designated 

Federal Official, Ms. Tia Haynes (see 

contact information below). 

Committee Name: Substance Abuse and 

Mental Health Services Administration, 

Center for Substance Abuse Prevention 

National Advisory Council. 

Date/Time/Type: June 9, 2010, 1 p.m. to 4 

p.m.: Closed. 

Place: 1 Choke Cherry Road, Conference 

Room 4–1058, Rockville, Maryland 20857. 

Contact: Tia Haynes, Designated Federal 

Official, SAMHSA/CSAP National Advisory 

Council, 1 Choke Cherry Road, Room 4–1066, 

Rockville, MD 20857, Telephone: (240) 276– 

2436; FAX: (240) 276–2430. E-mail: 

tia.haynes@samhsa.hhs.gov. 

Toian Vaughn, 

Committee Management Officer, Substance 

Abuse and Mental Health Services 

Administration. 

[FR Doc. 2010–12208 Filed 5–20–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Brain Function and Structure. 

Date: June 8, 2010. 

Time: 9 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kevin Walton, PhD, 

Scientific Review Officer, Center for 


emcdonald on DSK2BSOYB1PROD with NOTICES
28624 Federal Register / Vol. 75, No. 98 / Friday, May 21, 2010 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5200, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1785, kevin.walton@nih.hhs.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA RM09– 

002: National Centers for Biomedical 

Computing. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Amy L. Rubinstein, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm 5152, MSC 

7844, Bethesda, MD 20892, 301–435–1159, 

rubinsteinal@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Xenobiotic and Nutrient Disposition and 

Action Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Chicago O’Hare Airport, 

O’Hare International Airport, Chicago, IL 

60666. 

Contact Person: Patricia Greenwel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2172, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1169, greenwep@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Gastrointestinal Mucosal Pathobiology Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Avenue Hotel, 160 E. Huron Street, 

Chicago, IL 60611. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

0682, perrinp@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group, 

Tumor Microenvironment Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko, 222 Mason Street, San 

Francisco, CA 94102. 

Contact Person: Eun Ah Cho, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892, (301) 451– 

4467, choe@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Hepatobiliary Pathophysiology Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott Magnificent 

Mile Downtown, 165 E. Ontario Street, 

Chicago, IL 60611. 

Contact Person: Rass M. Shayiq, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

2359, shayiqr@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Clinical, Integrative and Molecular 

Gastroenterology Study Section. 

Date: June 14, 2010. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Avenue Hotel, 160 E. Huron Street, 

Chicago, IL 60611. 

Contact Person: Najma Begum, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2186, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1243, begumn@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group, 

Musculoskeletal Tissue Engineering Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Jean D. Sipe, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4106, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1743, sipej@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group, Motor Function, Speech and 

Rehabilitation Study Section. 

Date: June 14, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Old Town Alexandria, 

901 North Fairfax Street, Alexandria, VA 

22314. 

Contact Person: Biao Tian, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3166, MSC 7848, Bethesda, MD 

20892, 301–402–4411, tianbi@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Biology and 

Diseases of the Posterior Eye Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Michael H. Chaitin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

0910, chaitinm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Pregnancy and Reproduction. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Gary Hunnicutt, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, 301–435– 

0229, gary.hunnicutt@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Biophysical and Physiological 

Neuroscience. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Eugene Carstea, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 408– 

9756, carsteae@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Shared 

Instrumentation: Electron Microscopy. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Noni Byrnes, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5130, 

MSC 7840, Bethesda, MD 20892, (301) 435– 

1023, byrnesn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ARRA: 

Color Vision. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Michael H. Chaitin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

0910, chaitinm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Trans IRG 

Review of Cancer Imaging Proposals. 

Date: June 14, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 


emcdonald on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 98 / Friday, May 21, 2010 / Notices 28625 

Contact Person: Eileen W Bradley, DSC, 

Chief, SBIB IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5100, MSC 7854, Bethesda, MD 

20892, (301) 435–1179, bradleye@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, Aging Systems and Geriatrics Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Allerton Hotel, 701 North Michigan 

Avenue, Chicago, IL 60611. 

Contact Person: James P. Harwood, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1256, harwoodj@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Integrative Nutrition and Metabolic Processes 

Study Section. 

Date: June 14, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Sooja K Kim, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6182, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

1780, kims@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, 

Prokaryotic Cell and Molecular Biology 

Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Diane L. Stassi, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3202, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2514, stassid@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Pathobiology of Kidney Disease Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Chicago O’Hare Airport, 

O’Hare International Airport, Chicago, IL 

60666. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2176, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1778, khanm@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Clinical Oncology Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Malaya Chatterjee, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20817, (301) 806– 

2515, chatterm@csr.nih.gov. 

Name of Committee: Oncology 1–Basic 

Translational Integrated Review Group, 

Cancer Etiology Study Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington, 1515 

Rhode Island Avenue, NW., Washington, DC 

20005. 

Contact Person: Cathleen L Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–443– 

4512, cooperc@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Vascular Cell and Molecular Biology Study 

Section. 

Date: June 14–15, 2010. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Chicago Hotel, 505 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Anshumali Chaudhari, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1210, chaudhaa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR10–082: 

Shared Equipment for Macromolecular X-ray 

and Light Scattering. 

Date: June 14–15, 2010. 

Time: 8:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David R. Jollie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1722, jollieda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical and 

Research Ethics. 

Date: June 14–15, 2010. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Karin F. Helmers, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ARRA: 

Motor Function, Speech and Rehabilitation 

Competitive Revisions. 

Date: June 14, 2010. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Old Town Alexandria, 

901 North Fairfax Street, Alexandria, VA 

22314. 

Contact Person: Biao Tian, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, 

tianbi@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 14, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12154 Filed 5–20–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Assessment of 

Post-Treatment Lyme Disease 

Syndrome, Funding Opportunity 

Announcement (FOA) CK10–004, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:30 p.m.–4:30 p.m., June 

23, 2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Assessment of Post-Treatment 

Lyme Disease Syndrome,’’ FOA CK10–004. 

Contact Person for More Information: 

Maurine Goodman, MA, MPH, Scientific 

Review Administrator, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–4737. 


emcdonald on DSK2BSOYB1PROD with NOTICES